These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 19687510)

  • 1. von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke.
    Zhao BQ; Chauhan AK; Canault M; Patten IS; Yang JJ; Dockal M; Scheiflinger F; Wagner DD
    Blood; 2009 Oct; 114(15):3329-34. PubMed ID: 19687510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADAMTS13 reduces VWF-mediated acute inflammation following focal cerebral ischemia in mice.
    Khan MM; Motto DG; Lentz SR; Chauhan AK
    J Thromb Haemost; 2012 Aug; 10(8):1665-71. PubMed ID: 22712744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial Cell-Derived von Willebrand Factor Is the Major Determinant That Mediates von Willebrand Factor-Dependent Acute Ischemic Stroke by Promoting Postischemic Thrombo-Inflammation.
    Dhanesha N; Prakash P; Doddapattar P; Khanna I; Pollpeter MJ; Nayak MK; Staber JM; Chauhan AK
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1829-37. PubMed ID: 27444201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant ADAMTS13 reduces tissue plasminogen activator-induced hemorrhage after stroke in mice.
    Wang L; Fan W; Cai P; Fan M; Zhu X; Dai Y; Sun C; Cheng Y; Zheng P; Zhao BQ
    Ann Neurol; 2013 Feb; 73(2):189-98. PubMed ID: 23280993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADAMTS13 gene deletion aggravates ischemic brain damage: a possible neuroprotective role of ADAMTS13 by ameliorating postischemic hypoperfusion.
    Fujioka M; Hayakawa K; Mishima K; Kunizawa A; Irie K; Higuchi S; Nakano T; Muroi C; Fukushima H; Sugimoto M; Banno F; Kokame K; Miyata T; Fujiwara M; Okuchi K; Nishio K
    Blood; 2010 Feb; 115(8):1650-3. PubMed ID: 19965676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a mouse model to elucidate the phenotypic effects of the von Willebrand factor cleavage mutants, Y1605A/M1606A and R1597W.
    Pruss CM; Golder M; Bryant A; Hegadorn C; Haberichter S; Lillicrap D
    J Thromb Haemost; 2012 May; 10(5):940-50. PubMed ID: 22372972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective anti-inflammatory effect of ADAMTS13 on myocardial ischemia/reperfusion injury in mice.
    De Meyer SF; Savchenko AS; Haas MS; Schatzberg D; Carroll MC; Schiviz A; Dietrich B; Rottensteiner H; Scheiflinger F; Wagner DD
    Blood; 2012 Dec; 120(26):5217-23. PubMed ID: 22915644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADAMTS13 gene deletion enhances plasma high-mobility group box1 elevation and neuroinflammation in brain ischemia-reperfusion injury.
    Fujioka M; Nakano T; Hayakawa K; Irie K; Akitake Y; Sakamoto Y; Mishima K; Muroi C; Yonekawa Y; Banno F; Kokame K; Miyata T; Nishio K; Okuchi K; Iwasaki K; Fujiwara M; Siesjö BK
    Neurol Sci; 2012 Oct; 33(5):1107-15. PubMed ID: 22212812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An IAP retrotransposon in the mouse ADAMTS13 gene creates ADAMTS13 variant proteins that are less effective in cleaving von Willebrand factor multimers.
    Zhou W; Bouhassira EE; Tsai HM
    Blood; 2007 Aug; 110(3):886-93. PubMed ID: 17426255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interplay between ADAMTS13 and von Willebrand factor in inherited and acquired thrombotic microangiopathies.
    Soejima K; Nakagaki T
    Semin Hematol; 2005 Jan; 42(1):56-62. PubMed ID: 15662617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADAMTS13 controls vascular remodeling by modifying VWF reactivity during stroke recovery.
    Xu H; Cao Y; Yang X; Cai P; Kang L; Zhu X; Luo H; Lu L; Wei L; Bai X; Zhu Y; Zhao BQ; Fan W
    Blood; 2017 Jul; 130(1):11-22. PubMed ID: 28428179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carboxyl terminus of ADAMTS13 directly inhibits platelet aggregation and ultra large von Willebrand factor string formation under flow in a free-thiol-dependent manner.
    Bao J; Xiao J; Mao Y; Zheng XL
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):397-407. PubMed ID: 24357063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in von Willebrand factor-cleaving protease (ADAMTS13) activity after infusion of desmopressin.
    Reiter RA; Knöbl P; Varadi K; Turecek PL
    Blood; 2003 Feb; 101(3):946-8. PubMed ID: 12393734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning, expression, and functional characterization of the von Willebrand factor-cleaving protease (ADAMTS13).
    Plaimauer B; Zimmermann K; Völkel D; Antoine G; Kerschbaumer R; Jenab P; Furlan M; Gerritsen H; Lämmle B; Schwarz HP; Scheiflinger F
    Blood; 2002 Nov; 100(10):3626-32. PubMed ID: 12393399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of ADAMTS13 to von Willebrand factor.
    Majerus EM; Anderson PJ; Sadler JE
    J Biol Chem; 2005 Jun; 280(23):21773-8. PubMed ID: 15824096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Von Willebrand factor and ADAMTS13 in arterial thrombosis: a systematic review and meta-analysis.
    Sonneveld MA; de Maat MP; Leebeek FW
    Blood Rev; 2014 Jul; 28(4):167-78. PubMed ID: 24825749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed treatment with ADAMTS13 ameliorates cerebral ischemic injury without hemorrhagic complication.
    Nakano T; Irie K; Hayakawa K; Sano K; Nakamura Y; Tanaka M; Yamashita Y; Satho T; Fujioka M; Muroi C; Matsuo K; Ishikura H; Futagami K; Mishima K
    Brain Res; 2015 Oct; 1624():330-335. PubMed ID: 26254727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Keeping von Willebrand Factor under Control: Alternatives for ADAMTS13.
    Tersteeg C; Fijnheer R; Pasterkamp G; de Groot PG; Vanhoorelbeke K; de Maat S; Maas C
    Semin Thromb Hemost; 2016 Feb; 42(1):9-17. PubMed ID: 26595154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An amino acid polymorphism in von Willebrand factor correlates with increased susceptibility to proteolysis by ADAMTS13.
    Bowen DJ; Collins PW
    Blood; 2004 Feb; 103(3):941-7. PubMed ID: 14525793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degradation of circulating von Willebrand factor and its regulator ADAMTS13 implicates secreted Bacillus anthracis metalloproteases in anthrax consumptive coagulopathy.
    Chung MC; Popova TG; Jorgensen SC; Dong L; Chandhoke V; Bailey CL; Popov SG
    J Biol Chem; 2008 Apr; 283(15):9531-42. PubMed ID: 18263586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.